

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.17988114 |
| 2 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.04810005 |
| 3 | regulation of gamma-delta T cell activation (GO:0046643) | 4.84005780 |
| 4 | B cell receptor signaling pathway (GO:0050853) | 4.61289123 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.47104051 |
| 6 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.39809642 |
| 7 | positive regulation of B cell differentiation (GO:0045579) | 3.92327708 |
| 8 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.84383699 |
| 9 | cellular extravasation (GO:0045123) | 3.83005711 |
| 10 | regulation of superoxide anion generation (GO:0032928) | 3.81026285 |
| 11 | cellular response to interleukin-15 (GO:0071350) | 3.77814846 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 3.71337801 |
| 13 | positive regulation by symbiont of host defense response (GO:0052509) | 3.71337801 |
| 14 | modulation by symbiont of host defense response (GO:0052031) | 3.71337801 |
| 15 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.71337801 |
| 16 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.71337801 |
| 17 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.71337801 |
| 18 | negative regulation of histone methylation (GO:0031061) | 3.69965496 |
| 19 | detection of bacterium (GO:0016045) | 3.58322059 |
| 20 | defense response to protozoan (GO:0042832) | 3.54611265 |
| 21 | response to muramyl dipeptide (GO:0032495) | 3.53960684 |
| 22 | immunoglobulin mediated immune response (GO:0016064) | 3.50813583 |
| 23 | detection of other organism (GO:0098543) | 3.45440115 |
| 24 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.43981061 |
| 25 | regulation of histone H3-K27 methylation (GO:0061085) | 3.42621443 |
| 26 | positive thymic T cell selection (GO:0045059) | 3.40636917 |
| 27 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.38930018 |
| 28 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.37825692 |
| 29 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.37515006 |
| 30 | germinal center formation (GO:0002467) | 3.35864039 |
| 31 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.33804289 |
| 32 | regulation of B cell differentiation (GO:0045577) | 3.32236595 |
| 33 | T cell selection (GO:0045058) | 3.29352605 |
| 34 | B cell homeostasis (GO:0001782) | 3.24785674 |
| 35 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.24319614 |
| 36 | hepatocyte apoptotic process (GO:0097284) | 3.22572511 |
| 37 | response to protozoan (GO:0001562) | 3.21160873 |
| 38 | protein localization to kinetochore (GO:0034501) | 3.15908350 |
| 39 | regulation of histone H3-K9 methylation (GO:0051570) | 3.14387248 |
| 40 | response to type I interferon (GO:0034340) | 3.13691824 |
| 41 | regulation of mast cell degranulation (GO:0043304) | 3.13450052 |
| 42 | negative regulation of interleukin-8 production (GO:0032717) | 3.12860749 |
| 43 | serine transport (GO:0032329) | 3.12652706 |
| 44 | negative regulation of T cell mediated immunity (GO:0002710) | 3.12369984 |
| 45 | regulation of antigen processing and presentation (GO:0002577) | 3.11407088 |
| 46 | negative regulation of innate immune response (GO:0045824) | 3.11404161 |
| 47 | protein localization to chromosome, centromeric region (GO:0071459) | 3.10638654 |
| 48 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.08779917 |
| 49 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.08509461 |
| 50 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.08509461 |
| 51 | type I interferon signaling pathway (GO:0060337) | 3.07804227 |
| 52 | cellular response to type I interferon (GO:0071357) | 3.07804227 |
| 53 | T cell migration (GO:0072678) | 3.06505485 |
| 54 | mannose metabolic process (GO:0006013) | 3.04924518 |
| 55 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.03752547 |
| 56 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.03578553 |
| 57 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.03578553 |
| 58 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.02955677 |
| 59 | regulation of RNA export from nucleus (GO:0046831) | 3.01908287 |
| 60 | L-serine transport (GO:0015825) | 3.01583427 |
| 61 | neutrophil mediated immunity (GO:0002446) | 3.01473296 |
| 62 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.01403752 |
| 63 | positive regulation of defense response to virus by host (GO:0002230) | 3.01078177 |
| 64 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.00806800 |
| 65 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.99938649 |
| 66 | respiratory burst (GO:0045730) | 2.97417018 |
| 67 | positive regulation of antigen processing and presentation (GO:0002579) | 2.96634658 |
| 68 | positive regulation of isotype switching (GO:0045830) | 2.95695095 |
| 69 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.95137385 |
| 70 | regulation of granulocyte differentiation (GO:0030852) | 2.93759491 |
| 71 | activated T cell proliferation (GO:0050798) | 2.92914916 |
| 72 | thymic T cell selection (GO:0045061) | 2.92252361 |
| 73 | negative thymic T cell selection (GO:0045060) | 2.91138273 |
| 74 | negative T cell selection (GO:0043383) | 2.90659737 |
| 75 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 2.90162053 |
| 76 | regulation of defense response to virus by host (GO:0050691) | 2.89983606 |
| 77 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.88165656 |
| 78 | negative regulation of interleukin-6 production (GO:0032715) | 2.87596108 |
| 79 | interferon-gamma secretion (GO:0072643) | 2.86210895 |
| 80 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.83053409 |
| 81 | V(D)J recombination (GO:0033151) | 2.82945705 |
| 82 | response to peptidoglycan (GO:0032494) | 2.81667017 |
| 83 | regulation of mast cell activation (GO:0033003) | 2.79507188 |
| 84 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.79496743 |
| 85 | NIK/NF-kappaB signaling (GO:0038061) | 2.77673840 |
| 86 | neutrophil activation involved in immune response (GO:0002283) | 2.77551372 |
| 87 | positive T cell selection (GO:0043368) | 2.76564422 |
| 88 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.75829950 |
| 89 | detection of external biotic stimulus (GO:0098581) | 2.75098981 |
| 90 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.73115012 |
| 91 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.72662940 |
| 92 | positive regulation of interferon-alpha production (GO:0032727) | 2.72579841 |
| 93 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.72446272 |
| 94 | neutrophil activation (GO:0042119) | 2.70814452 |
| 95 | negative regulation of interleukin-12 production (GO:0032695) | 2.70733215 |
| 96 | regulation of germinal center formation (GO:0002634) | 2.69743456 |
| 97 | T-helper cell differentiation (GO:0042093) | 2.69285735 |
| 98 | protein localization to chromosome (GO:0034502) | 2.68897435 |
| 99 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.68687828 |
| 100 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.67886907 |
| 101 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.67179534 |
| 102 | macrophage activation involved in immune response (GO:0002281) | 2.64627899 |
| 103 | mitotic chromosome condensation (GO:0007076) | 2.63909789 |
| 104 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.60974018 |
| 105 | mitotic nuclear envelope disassembly (GO:0007077) | 2.58850557 |
| 106 | positive regulation of immunoglobulin production (GO:0002639) | 2.58285408 |
| 107 | regulation of sister chromatid cohesion (GO:0007063) | 2.56298532 |
| 108 | tolerance induction (GO:0002507) | 2.55137357 |
| 109 | natural killer cell differentiation (GO:0001779) | 2.54151924 |
| 110 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.52697713 |
| 111 | leukocyte aggregation (GO:0070486) | 2.51724469 |
| 112 | response to laminar fluid shear stress (GO:0034616) | 2.50109778 |
| 113 | heterochromatin organization (GO:0070828) | 2.47760104 |
| 114 | nuclear pore complex assembly (GO:0051292) | 2.46339146 |
| 115 | T cell homeostasis (GO:0043029) | 2.45662797 |
| 116 | negative regulation of phagocytosis (GO:0050765) | 2.45439060 |
| 117 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.45108609 |
| 118 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.45108609 |
| 119 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.45108609 |
| 120 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.44694741 |
| 121 | positive regulation of chromosome segregation (GO:0051984) | 2.43525316 |
| 122 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.43394313 |
| 123 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.43187055 |
| 124 | negative regulation of cell killing (GO:0031342) | 2.43187055 |
| 125 | positive regulation of histone deacetylation (GO:0031065) | 2.42852179 |
| 126 | regulation of translation in response to stress (GO:0043555) | 2.41705343 |
| 127 | nuclear envelope disassembly (GO:0051081) | 2.41190537 |
| 128 | membrane disassembly (GO:0030397) | 2.41190537 |
| 129 | positive regulation of B cell activation (GO:0050871) | 2.39743783 |
| 130 | lymph vessel development (GO:0001945) | 2.39538469 |
| 131 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.38925125 |
| 132 | maturation of 5.8S rRNA (GO:0000460) | 2.33807193 |
| 133 | mitotic sister chromatid segregation (GO:0000070) | 2.33414896 |
| 134 | positive regulation of DNA recombination (GO:0045911) | 2.31651772 |
| 135 | mitotic metaphase plate congression (GO:0007080) | 2.31039129 |
| 136 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.30796588 |
| 137 | regulation of Cdc42 GTPase activity (GO:0043088) | 2.30426906 |
| 138 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.30340062 |
| 139 | negative regulation of gene silencing (GO:0060969) | 2.30262191 |
| 140 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.30077184 |
| 141 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.29814961 |
| 142 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.28464799 |
| 143 | chromatin assembly (GO:0031497) | 2.28051516 |
| 144 | regulation of response to interferon-gamma (GO:0060330) | 2.26404385 |
| 145 | response to interleukin-15 (GO:0070672) | 2.26145584 |
| 146 | interferon-gamma production (GO:0032609) | 2.26005713 |
| 147 | regulation of spindle organization (GO:0090224) | 2.24995183 |
| 148 | positive regulation of granulocyte differentiation (GO:0030854) | 2.24978048 |
| 149 | histone H3-K4 methylation (GO:0051568) | 2.24703508 |
| 150 | regulation of B cell proliferation (GO:0030888) | 2.24051202 |
| 151 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.23935151 |
| 152 | negative regulation of bone resorption (GO:0045779) | 2.23659298 |
| 153 | positive regulation of bone remodeling (GO:0046852) | 2.23052101 |
| 154 | positive regulation of bone resorption (GO:0045780) | 2.23052101 |
| 155 | regulation of superoxide metabolic process (GO:0090322) | 2.22825109 |
| 156 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.22292163 |
| 157 | histone H3-K9 demethylation (GO:0033169) | 2.21755976 |
| 158 | positive regulation of protein deacetylation (GO:0090312) | 2.20999136 |
| 159 | lymphocyte homeostasis (GO:0002260) | 2.20044269 |
| 160 | sister chromatid segregation (GO:0000819) | 2.19394061 |
| 161 | regulation of histone methylation (GO:0031060) | 2.18267758 |
| 162 | positive regulation by host of viral transcription (GO:0043923) | 2.17917242 |
| 163 | histone H2A monoubiquitination (GO:0035518) | 2.16711595 |
| 164 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 2.16276894 |
| 165 | regulation of mitotic spindle organization (GO:0060236) | 2.15970472 |
| 166 | T cell costimulation (GO:0031295) | 2.15700564 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.37449786 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.20439828 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.83866532 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.30691793 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.74165051 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.68803137 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.63629639 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.60200148 |
| 9 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.48021528 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.45905070 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.40757995 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.40620410 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.29324197 |
| 14 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.29063485 |
| 15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.27937613 |
| 16 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.12146174 |
| 17 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.00565279 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 1.99384465 |
| 19 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.97698492 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.94064246 |
| 21 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93585477 |
| 22 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.90826628 |
| 23 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.90761103 |
| 24 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.90399813 |
| 25 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.90280523 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 1.86844352 |
| 27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.86101065 |
| 28 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.80089901 |
| 29 | MYB_26560356_Chip-Seq_TH1_Human | 1.79600080 |
| 30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.79452153 |
| 31 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.75220847 |
| 32 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.75018646 |
| 33 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.74987187 |
| 34 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.74119240 |
| 35 | * P68_20966046_ChIP-Seq_HELA_Human | 1.72505683 |
| 36 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.69890824 |
| 37 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.69789259 |
| 38 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.64429906 |
| 39 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.64202778 |
| 40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.63202365 |
| 41 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.61614311 |
| 42 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.59556810 |
| 43 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.57834301 |
| 44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.57694557 |
| 45 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.53999086 |
| 46 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.51478043 |
| 47 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.48388174 |
| 48 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.48272666 |
| 49 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.46167972 |
| 50 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.44885846 |
| 51 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42979443 |
| 52 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.42840666 |
| 53 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.41781380 |
| 54 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41377012 |
| 55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41365792 |
| 56 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.40656261 |
| 57 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.37238111 |
| 58 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.37194439 |
| 59 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37080620 |
| 60 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.37069241 |
| 61 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.36569546 |
| 62 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.35530531 |
| 63 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.34469946 |
| 64 | MAF_26560356_Chip-Seq_TH2_Human | 1.34084280 |
| 65 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.32812120 |
| 66 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.32767222 |
| 67 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.32657606 |
| 68 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30987390 |
| 69 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.29799844 |
| 70 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.29690104 |
| 71 | * P300_27268052_Chip-Seq_Bcells_Human | 1.28026253 |
| 72 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.27205509 |
| 73 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.26289656 |
| 74 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25809370 |
| 75 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.25770365 |
| 76 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.25760053 |
| 77 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.24957024 |
| 78 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24269982 |
| 79 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24096971 |
| 80 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24011963 |
| 81 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.23888196 |
| 82 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.23641051 |
| 83 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23342643 |
| 84 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.22290843 |
| 85 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.21214301 |
| 86 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.20482291 |
| 87 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.20214634 |
| 88 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.19105798 |
| 89 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.19023013 |
| 90 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.17615118 |
| 91 | GATA3_26560356_Chip-Seq_TH2_Human | 1.17530929 |
| 92 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.16683077 |
| 93 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.16244928 |
| 94 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.15861430 |
| 95 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15337022 |
| 96 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13403052 |
| 97 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.12464153 |
| 98 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.12311221 |
| 99 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.11957369 |
| 100 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10715282 |
| 101 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.10551834 |
| 102 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.10202386 |
| 103 | GATA1_22025678_ChIP-Seq_K562_Human | 1.09430426 |
| 104 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.08549505 |
| 105 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.08417253 |
| 106 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.06722539 |
| 107 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.05657620 |
| 108 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.05578672 |
| 109 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.05299047 |
| 110 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.05136409 |
| 111 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05119133 |
| 112 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.05076327 |
| 113 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.04096077 |
| 114 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.03675019 |
| 115 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.03579162 |
| 116 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01746587 |
| 117 | ATF3_27146783_Chip-Seq_COLON_Human | 1.01624681 |
| 118 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.01040457 |
| 119 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.00716821 |
| 120 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00223427 |
| 121 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.99720985 |
| 122 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.99412555 |
| 123 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98623971 |
| 124 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98524026 |
| 125 | SA1_27219007_Chip-Seq_Bcells_Human | 0.98434500 |
| 126 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.98351942 |
| 127 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98024942 |
| 128 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.97955495 |
| 129 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.97450823 |
| 130 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.96943194 |
| 131 | SPI1_23127762_ChIP-Seq_K562_Human | 0.95874887 |
| 132 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95563732 |
| 133 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.95102217 |
| 134 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.95020044 |
| 135 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.94990104 |
| 136 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.94150322 |
| 137 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93976359 |
| 138 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93333512 |
| 139 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.93231852 |
| 140 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.90850470 |
| 141 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.90815441 |
| 142 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90763296 |
| 143 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.90548987 |
| 144 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.88092396 |
| 145 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.87596394 |
| 146 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.87507396 |
| 147 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.87432269 |
| 148 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.86314647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 2.93608509 |
| 2 | MP0003172_abnormal_lysosome_physiology | 2.75116093 |
| 3 | MP0001800_abnormal_humoral_immune | 2.68765345 |
| 4 | MP0004381_abnormal_hair_follicle | 2.64079623 |
| 5 | MP0003693_abnormal_embryo_hatching | 2.48303290 |
| 6 | MP0005387_immune_system_phenotype | 2.38261654 |
| 7 | MP0001790_abnormal_immune_system | 2.38261654 |
| 8 | MP0003763_abnormal_thymus_physiology | 2.38114017 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.37426304 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.35040005 |
| 11 | MP0000685_abnormal_immune_system | 2.32795748 |
| 12 | MP0010352_gastrointestinal_tract_polyps | 2.25838906 |
| 13 | MP0003303_peritoneal_inflammation | 2.19897406 |
| 14 | MP0009333_abnormal_splenocyte_physiolog | 2.16867204 |
| 15 | MP0002396_abnormal_hematopoietic_system | 2.16847315 |
| 16 | * MP0002452_abnormal_antigen_presenting | 2.08069285 |
| 17 | MP0003111_abnormal_nucleus_morphology | 2.04381043 |
| 18 | MP0002148_abnormal_hypersensitivity_rea | 2.01527445 |
| 19 | * MP0002398_abnormal_bone_marrow | 2.01518121 |
| 20 | MP0005075_abnormal_melanosome_morpholog | 2.00208289 |
| 21 | MP0004957_abnormal_blastocyst_morpholog | 1.98426222 |
| 22 | MP0003077_abnormal_cell_cycle | 1.98366130 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 1.92590263 |
| 24 | MP0010094_abnormal_chromosome_stability | 1.91800890 |
| 25 | MP0005076_abnormal_cell_differentiation | 1.90751411 |
| 26 | MP0000689_abnormal_spleen_morphology | 1.86200531 |
| 27 | MP0003566_abnormal_cell_adhesion | 1.86150073 |
| 28 | MP0005671_abnormal_response_to | 1.85334820 |
| 29 | MP0003300_gastrointestinal_ulcer | 1.82780492 |
| 30 | MP0006054_spinal_hemorrhage | 1.81935179 |
| 31 | * MP0002420_abnormal_adaptive_immunity | 1.79504522 |
| 32 | MP0005000_abnormal_immune_tolerance | 1.79320725 |
| 33 | MP0002723_abnormal_immune_serum | 1.75340132 |
| 34 | * MP0001819_abnormal_immune_cell | 1.75238880 |
| 35 | * MP0002722_abnormal_immune_system | 1.74771891 |
| 36 | MP0008057_abnormal_DNA_replication | 1.74457843 |
| 37 | MP0005023_abnormal_wound_healing | 1.74296976 |
| 38 | MP0001986_abnormal_taste_sensitivity | 1.71995940 |
| 39 | * MP0000716_abnormal_immune_system | 1.70659656 |
| 40 | MP0000490_abnormal_crypts_of | 1.69381592 |
| 41 | MP0000703_abnormal_thymus_morphology | 1.68603676 |
| 42 | MP0003436_decreased_susceptibility_to | 1.67789829 |
| 43 | MP0004808_abnormal_hematopoietic_stem | 1.60714165 |
| 44 | MP0002877_abnormal_melanocyte_morpholog | 1.60005362 |
| 45 | MP0000015_abnormal_ear_pigmentation | 1.59406352 |
| 46 | MP0003183_abnormal_peptide_metabolism | 1.59073594 |
| 47 | MP0000350_abnormal_cell_proliferation | 1.58314264 |
| 48 | MP0004947_skin_inflammation | 1.58137513 |
| 49 | MP0004510_myositis | 1.56628072 |
| 50 | MP0004264_abnormal_extraembryonic_tissu | 1.56453678 |
| 51 | MP0001849_ear_inflammation | 1.56012456 |
| 52 | MP0008007_abnormal_cellular_replicative | 1.52899028 |
| 53 | MP0002405_respiratory_system_inflammati | 1.50906046 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.49604176 |
| 55 | MP0005451_abnormal_body_composition | 1.49279351 |
| 56 | MP0001873_stomach_inflammation | 1.49217555 |
| 57 | * MP0002429_abnormal_blood_cell | 1.49155623 |
| 58 | MP0003191_abnormal_cellular_cholesterol | 1.46845763 |
| 59 | MP0002166_altered_tumor_susceptibility | 1.46382492 |
| 60 | MP0006082_CNS_inflammation | 1.42797903 |
| 61 | MP0002132_abnormal_respiratory_system | 1.41419654 |
| 62 | MP0001730_embryonic_growth_arrest | 1.35787185 |
| 63 | MP0005058_abnormal_lysosome_morphology | 1.35037400 |
| 64 | MP0009278_abnormal_bone_marrow | 1.32299828 |
| 65 | MP0002019_abnormal_tumor_incidence | 1.27534798 |
| 66 | MP0002006_tumorigenesis | 1.25890382 |
| 67 | MP0003279_aneurysm | 1.25110323 |
| 68 | MP0008469_abnormal_protein_level | 1.23319536 |
| 69 | MP0003453_abnormal_keratinocyte_physiol | 1.23196144 |
| 70 | MP0001348_abnormal_lacrimal_gland | 1.21280409 |
| 71 | MP0000465_gastrointestinal_hemorrhage | 1.20537187 |
| 72 | MP0005025_abnormal_response_to | 1.19196108 |
| 73 | MP0008260_abnormal_autophagy | 1.18199011 |
| 74 | MP0009764_decreased_sensitivity_to | 1.17298274 |
| 75 | MP0000733_abnormal_muscle_development | 1.13614166 |
| 76 | MP0001845_abnormal_inflammatory_respons | 1.11887750 |
| 77 | MP0005174_abnormal_tail_pigmentation | 1.11563775 |
| 78 | MP0009785_altered_susceptibility_to | 1.09906526 |
| 79 | MP0002086_abnormal_extraembryonic_tissu | 1.07459764 |
| 80 | MP0003091_abnormal_cell_migration | 1.06542643 |
| 81 | MP0003866_abnormal_defecation | 1.05987039 |
| 82 | MP0001672_abnormal_embryogenesis/_devel | 1.04289774 |
| 83 | MP0005380_embryogenesis_phenotype | 1.04289774 |
| 84 | MP0001697_abnormal_embryo_size | 1.04254725 |
| 85 | MP0000858_altered_metastatic_potential | 1.03151358 |
| 86 | MP0002088_abnormal_embryonic_growth/wei | 1.02318354 |
| 87 | MP0003984_embryonic_growth_retardation | 1.01861613 |
| 88 | MP0002419_abnormal_innate_immunity | 1.00541482 |
| 89 | MP0002933_joint_inflammation | 0.99018758 |
| 90 | MP0002254_reproductive_system_inflammat | 0.97613689 |
| 91 | MP0000372_irregular_coat_pigmentation | 0.96911206 |
| 92 | MP0003045_fibrosis | 0.95957688 |
| 93 | MP0004197_abnormal_fetal_growth/weight/ | 0.95835887 |
| 94 | MP0005310_abnormal_salivary_gland | 0.93659679 |
| 95 | MP0005621_abnormal_cell_physiology | 0.92345896 |
| 96 | MP0005397_hematopoietic_system_phenotyp | 0.91553736 |
| 97 | MP0001545_abnormal_hematopoietic_system | 0.91553736 |
| 98 | MP0001851_eye_inflammation | 0.91320826 |
| 99 | MP0004130_abnormal_muscle_cell | 0.90820032 |
| 100 | MP0009931_abnormal_skin_appearance | 0.89784775 |
| 101 | MP0002085_abnormal_embryonic_tissue | 0.87625461 |
| 102 | MP0002080_prenatal_lethality | 0.86587630 |
| 103 | MP0009840_abnormal_foam_cell | 0.86157214 |
| 104 | MP0001879_abnormal_lymphatic_vessel | 0.86118025 |
| 105 | MP0001663_abnormal_digestive_system | 0.85479507 |
| 106 | MP0002928_abnormal_bile_duct | 0.85283913 |
| 107 | MP0000477_abnormal_intestine_morphology | 0.84534029 |
| 108 | MP0000313_abnormal_cell_death | 0.83929256 |
| 109 | MP0002060_abnormal_skin_morphology | 0.83681604 |
| 110 | MP0002084_abnormal_developmental_patter | 0.83544441 |
| 111 | MP0010307_abnormal_tumor_latency | 0.82967204 |
| 112 | MP0001915_intracranial_hemorrhage | 0.82458486 |
| 113 | MP0001853_heart_inflammation | 0.82451546 |
| 114 | MP0001216_abnormal_epidermal_layer | 0.82007076 |
| 115 | MP0010368_abnormal_lymphatic_system | 0.79780404 |
| 116 | MP0003448_altered_tumor_morphology | 0.79424641 |
| 117 | MP0005464_abnormal_platelet_physiology | 0.78092750 |
| 118 | MP0002925_abnormal_cardiovascular_devel | 0.77423727 |
| 119 | MP0003828_pulmonary_edema | 0.75641995 |
| 120 | MP0002009_preneoplasia | 0.75182439 |
| 121 | MP0000371_diluted_coat_color | 0.74107795 |
| 122 | MP0005501_abnormal_skin_physiology | 0.73935343 |
| 123 | MP0005083_abnormal_biliary_tract | 0.72231729 |
| 124 | MP0001533_abnormal_skeleton_physiology | 0.71062762 |
| 125 | MP0010030_abnormal_orbit_morphology | 0.70906923 |
| 126 | MP0004185_abnormal_adipocyte_glucose | 0.69857355 |
| 127 | MP0002998_abnormal_bone_remodeling | 0.69042281 |
| 128 | MP0002970_abnormal_white_adipose | 0.68724983 |
| 129 | MP0009115_abnormal_fat_cell | 0.68535438 |
| 130 | MP0005257_abnormal_intraocular_pressure | 0.66231617 |
| 131 | MP0000249_abnormal_blood_vessel | 0.65870238 |
| 132 | MP0002653_abnormal_ependyma_morphology | 0.65839629 |
| 133 | MP0003646_muscle_fatigue | 0.62671426 |
| 134 | MP0002693_abnormal_pancreas_physiology | 0.62048299 |
| 135 | MP0005360_urolithiasis | 0.61849990 |
| 136 | MP0001764_abnormal_homeostasis | 0.61001923 |
| 137 | MP0002136_abnormal_kidney_physiology | 0.60499573 |
| 138 | MP0008961_abnormal_basal_metabolism | 0.58858630 |
| 139 | MP0005390_skeleton_phenotype | 0.57932564 |
| 140 | MP0000609_abnormal_liver_physiology | 0.54922601 |
| 141 | MP0002277_abnormal_respiratory_mucosa | 0.54720807 |
| 142 | MP0008874_decreased_physiological_sensi | 0.54422328 |
| 143 | MP0001958_emphysema | 0.52642580 |
| 144 | MP0004883_abnormal_blood_vessel | 0.51163176 |
| 145 | MP0002163_abnormal_gland_morphology | 0.50427195 |
| 146 | MP0005670_abnormal_white_adipose | 0.49773967 |
| 147 | MP0000569_abnormal_digit_pigmentation | 0.49560566 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 4.54591662 |
| 2 | Myositis (HP:0100614) | 4.36592598 |
| 3 | Cellulitis (HP:0100658) | 4.28436662 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.05436479 |
| 5 | Recurrent viral infections (HP:0004429) | 4.04300801 |
| 6 | Papilloma (HP:0012740) | 3.88262588 |
| 7 | Verrucae (HP:0200043) | 3.88262588 |
| 8 | Abnormality of B cell number (HP:0010975) | 3.82300382 |
| 9 | B lymphocytopenia (HP:0010976) | 3.82300382 |
| 10 | Orchitis (HP:0100796) | 3.76775063 |
| 11 | Recurrent bronchitis (HP:0002837) | 3.72194868 |
| 12 | Optic neuritis (HP:0100653) | 3.64795790 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 3.64795790 |
| 14 | Stomatitis (HP:0010280) | 3.62172954 |
| 15 | Ulnar bowing (HP:0003031) | 3.51067311 |
| 16 | Gastrointestinal infarctions (HP:0005244) | 3.31490892 |
| 17 | Obstructive lung disease (HP:0006536) | 3.25498393 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 3.25498393 |
| 19 | Panhypogammaglobulinemia (HP:0003139) | 3.22935460 |
| 20 | T lymphocytopenia (HP:0005403) | 3.19335168 |
| 21 | Encephalitis (HP:0002383) | 3.16222909 |
| 22 | Recurrent skin infections (HP:0001581) | 3.15349286 |
| 23 | Chest pain (HP:0100749) | 3.11190660 |
| 24 | Abnormality of T cell number (HP:0011839) | 3.06075245 |
| 25 | Abnormality of the intervertebral disk (HP:0005108) | 3.03535673 |
| 26 | Colitis (HP:0002583) | 3.03455413 |
| 27 | Pulmonary infiltrates (HP:0002113) | 2.99825832 |
| 28 | Recurrent fungal infections (HP:0002841) | 2.96346989 |
| 29 | Abnormality of macrophages (HP:0004311) | 2.89271526 |
| 30 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.82950568 |
| 31 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.82631502 |
| 32 | Vertebral arch anomaly (HP:0008438) | 2.81202998 |
| 33 | Hemoptysis (HP:0002105) | 2.77556827 |
| 34 | Meningitis (HP:0001287) | 2.75856318 |
| 35 | Small epiphyses (HP:0010585) | 2.74112767 |
| 36 | Combined immunodeficiency (HP:0005387) | 2.72728761 |
| 37 | Emphysema (HP:0002097) | 2.71669588 |
| 38 | Pustule (HP:0200039) | 2.68327679 |
| 39 | Hypochromic anemia (HP:0001931) | 2.67869217 |
| 40 | Inflammation of the large intestine (HP:0002037) | 2.67778645 |
| 41 | Keratoconjunctivitis (HP:0001096) | 2.67720466 |
| 42 | Gastrointestinal inflammation (HP:0004386) | 2.61013939 |
| 43 | Abnormality of the fingertips (HP:0001211) | 2.59922730 |
| 44 | Congenital stationary night blindness (HP:0007642) | 2.57156541 |
| 45 | Aortic aneurysm (HP:0004942) | 2.56191068 |
| 46 | Recurrent sinusitis (HP:0011108) | 2.56181280 |
| 47 | J-shaped sella turcica (HP:0002680) | 2.55672095 |
| 48 | Keratoconjunctivitis sicca (HP:0001097) | 2.54903488 |
| 49 | Osteomyelitis (HP:0002754) | 2.54329149 |
| 50 | Sparse lateral eyebrow (HP:0005338) | 2.53236260 |
| 51 | Autoimmune thrombocytopenia (HP:0001973) | 2.50620053 |
| 52 | IgM deficiency (HP:0002850) | 2.48014618 |
| 53 | Increased IgM level (HP:0003496) | 2.47142458 |
| 54 | Gastrointestinal stroma tumor (HP:0100723) | 2.46454806 |
| 55 | Prolonged bleeding time (HP:0003010) | 2.46218113 |
| 56 | Epistaxis (HP:0000421) | 2.45508359 |
| 57 | Hemorrhage of the eye (HP:0011885) | 2.39994220 |
| 58 | Gingivitis (HP:0000230) | 2.37245499 |
| 59 | Abnormality of the pleura (HP:0002103) | 2.34307533 |
| 60 | Abnormality of T cells (HP:0002843) | 2.34102759 |
| 61 | Lymphopenia (HP:0001888) | 2.33967248 |
| 62 | Chronic otitis media (HP:0000389) | 2.32391044 |
| 63 | IgG deficiency (HP:0004315) | 2.29569749 |
| 64 | Long eyelashes (HP:0000527) | 2.28986722 |
| 65 | Dysostosis multiplex (HP:0000943) | 2.28561849 |
| 66 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.28525144 |
| 67 | Recurrent otitis media (HP:0000403) | 2.27889080 |
| 68 | Bowed forearm bones (HP:0003956) | 2.26320804 |
| 69 | Bowing of the arm (HP:0006488) | 2.26320804 |
| 70 | Protrusio acetabuli (HP:0003179) | 2.25307916 |
| 71 | Chronic sinusitis (HP:0011109) | 2.24694812 |
| 72 | Thyroiditis (HP:0100646) | 2.23786041 |
| 73 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.23736935 |
| 74 | Abnormality of the prostate (HP:0008775) | 2.23451857 |
| 75 | Severe combined immunodeficiency (HP:0004430) | 2.23325776 |
| 76 | Autoimmune hemolytic anemia (HP:0001890) | 2.22658121 |
| 77 | Arterial thrombosis (HP:0004420) | 2.20415115 |
| 78 | Hypergammaglobulinemia (HP:0010702) | 2.20005164 |
| 79 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.19777966 |
| 80 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.19777966 |
| 81 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.19777966 |
| 82 | Keratitis (HP:0000491) | 2.15957740 |
| 83 | Bronchitis (HP:0012387) | 2.15260901 |
| 84 | Cerebral aneurysm (HP:0004944) | 2.10938598 |
| 85 | Urticaria (HP:0001025) | 2.10675660 |
| 86 | Episodic fever (HP:0001954) | 2.10518917 |
| 87 | Eosinophilia (HP:0001880) | 2.10187456 |
| 88 | Eczematoid dermatitis (HP:0000976) | 2.06763306 |
| 89 | Periodontitis (HP:0000704) | 2.06590849 |
| 90 | Mucopolysacchariduria (HP:0008155) | 2.04115118 |
| 91 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.04115118 |
| 92 | Sepsis (HP:0100806) | 2.03236169 |
| 93 | Aortic dissection (HP:0002647) | 2.02310639 |
| 94 | Pulmonary embolism (HP:0002204) | 2.01974998 |
| 95 | Anorexia (HP:0002039) | 2.00825803 |
| 96 | Viral hepatitis (HP:0006562) | 1.98332036 |
| 97 | Skin rash (HP:0000988) | 1.97903316 |
| 98 | Aortic regurgitation (HP:0001659) | 1.96043059 |
| 99 | Petechiae (HP:0000967) | 1.95706398 |
| 100 | Lymphoma (HP:0002665) | 1.95500093 |
| 101 | Nasal polyposis (HP:0100582) | 1.95285373 |
| 102 | IgA deficiency (HP:0002720) | 1.93553377 |
| 103 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.92783282 |
| 104 | Recurrent cutaneous fungal infections (HP:0011370) | 1.92783282 |
| 105 | Spontaneous hematomas (HP:0007420) | 1.91586694 |
| 106 | Mitral stenosis (HP:0001718) | 1.91390037 |
| 107 | Neurodegeneration (HP:0002180) | 1.90461394 |
| 108 | Flattened epiphyses (HP:0003071) | 1.89284411 |
| 109 | Restrictive lung disease (HP:0002091) | 1.88988732 |
| 110 | Ocular albinism (HP:0001107) | 1.88888725 |
| 111 | Dilatation of the ascending aorta (HP:0005111) | 1.88213005 |
| 112 | Recurrent abscess formation (HP:0002722) | 1.87332181 |
| 113 | Skin ulcer (HP:0200042) | 1.86749008 |
| 114 | Obstructive sleep apnea (HP:0002870) | 1.86089575 |
| 115 | Recurrent lower respiratory tract infections (HP:0002783) | 1.86081565 |
| 116 | Patellar aplasia (HP:0006443) | 1.85735211 |
| 117 | Chronic diarrhea (HP:0002028) | 1.84886327 |
| 118 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.84763932 |
| 119 | Severe visual impairment (HP:0001141) | 1.83882287 |
| 120 | Broad face (HP:0000283) | 1.83701990 |
| 121 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.83197133 |
| 122 | Basal cell carcinoma (HP:0002671) | 1.82697777 |
| 123 | Limited elbow extension (HP:0001377) | 1.82600953 |
| 124 | Vasculitis (HP:0002633) | 1.80405204 |
| 125 | Recurrent bacterial skin infections (HP:0005406) | 1.80119929 |
| 126 | Recurrent pneumonia (HP:0006532) | 1.79483410 |
| 127 | Back pain (HP:0003418) | 1.78213331 |
| 128 | Leukocytosis (HP:0001974) | 1.74800602 |
| 129 | Increased IgE level (HP:0003212) | 1.73354972 |
| 130 | Long palpebral fissure (HP:0000637) | 1.73097790 |
| 131 | Rib fusion (HP:0000902) | 1.72850611 |
| 132 | Facial hemangioma (HP:0000329) | 1.71577702 |
| 133 | Cervical subluxation (HP:0003308) | 1.70891454 |
| 134 | Abnormality of T cell physiology (HP:0011840) | 1.70526757 |
| 135 | Anal stenosis (HP:0002025) | 1.70362051 |
| 136 | Mitral valve prolapse (HP:0001634) | 1.69737709 |
| 137 | Mediastinal lymphadenopathy (HP:0100721) | 1.69597982 |
| 138 | Mesomelia (HP:0003027) | 1.69141712 |
| 139 | Leukopenia (HP:0001882) | 1.67573760 |
| 140 | Multiple enchondromatosis (HP:0005701) | 1.65945511 |
| 141 | Granulocytopenia (HP:0001913) | 1.65864197 |
| 142 | Deviation of the thumb (HP:0009603) | 1.63842866 |
| 143 | Thin bony cortex (HP:0002753) | 1.61225783 |
| 144 | Thrombocytosis (HP:0001894) | 1.60322649 |
| 145 | Increased density of long bones (HP:0006392) | 1.60223920 |
| 146 | Blepharitis (HP:0000498) | 1.59813622 |
| 147 | Abnormality of eosinophils (HP:0001879) | 1.58866335 |
| 148 | Lip pit (HP:0100267) | 1.58212665 |
| 149 | Abnormality of the anterior horn cell (HP:0006802) | 1.58036328 |
| 150 | Degeneration of anterior horn cells (HP:0002398) | 1.58036328 |
| 151 | Spondylolisthesis (HP:0003302) | 1.57932799 |
| 152 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.56616604 |
| 153 | Osteolytic defects of the hand bones (HP:0009699) | 1.56616604 |
| 154 | Spinal cord lesions (HP:0100561) | 1.56480829 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K10 | 5.58809867 |
| 2 | CDK12 | 4.24045016 |
| 3 | ERN1 | 3.69200154 |
| 4 | MAP4K1 | 3.63220878 |
| 5 | STK10 | 3.22210138 |
| 6 | TRIB3 | 2.91054031 |
| 7 | RIPK4 | 2.82872745 |
| 8 | GRK6 | 2.74962647 |
| 9 | TNK2 | 2.44264553 |
| 10 | FES | 2.24833591 |
| 11 | EEF2K | 2.07581325 |
| 12 | NEK2 | 1.82628525 |
| 13 | TYK2 | 1.60685554 |
| 14 | PKN2 | 1.58532525 |
| 15 | ZAP70 | 1.55472684 |
| 16 | JAK3 | 1.52465776 |
| 17 | KIT | 1.47629812 |
| 18 | SIK3 | 1.43531962 |
| 19 | IRAK3 | 1.40843273 |
| 20 | MAP3K7 | 1.40297738 |
| 21 | CDK4 | 1.32403978 |
| 22 | MELK | 1.31265850 |
| 23 | LRRK2 | 1.26082635 |
| 24 | MAP3K11 | 1.25658705 |
| 25 | PRPF4B | 1.24385313 |
| 26 | ITK | 1.22854478 |
| 27 | PIM1 | 1.19906418 |
| 28 | MAP3K13 | 1.19793849 |
| 29 | MOS | 1.16720097 |
| 30 | CSF1R | 1.15819832 |
| 31 | MAPK11 | 1.15057482 |
| 32 | FGFR4 | 1.13535853 |
| 33 | BRD4 | 1.12481524 |
| 34 | NLK | 1.12373768 |
| 35 | CDK9 | 1.12313569 |
| 36 | FRK | 1.12291803 |
| 37 | JAK1 | 1.12132282 |
| 38 | BTK | 1.10068888 |
| 39 | MARK2 | 1.10055305 |
| 40 | MARK3 | 1.08420081 |
| 41 | SYK | 1.07096745 |
| 42 | BLK | 1.05699759 |
| 43 | CDC42BPA | 1.05354920 |
| 44 | CDK6 | 1.04411856 |
| 45 | SMG1 | 1.04232962 |
| 46 | MAP2K2 | 1.03999371 |
| 47 | MAP2K6 | 1.03557986 |
| 48 | TXK | 1.01950362 |
| 49 | STK3 | 1.01642583 |
| 50 | MST4 | 1.00471137 |
| 51 | TAOK1 | 1.00021364 |
| 52 | MATK | 0.99028377 |
| 53 | IRAK1 | 0.98093487 |
| 54 | MAP3K8 | 0.97871688 |
| 55 | RPS6KA4 | 0.97412602 |
| 56 | STK38L | 0.96417496 |
| 57 | STK4 | 0.95460319 |
| 58 | CSK | 0.94428047 |
| 59 | HCK | 0.92228071 |
| 60 | TGFBR2 | 0.90851209 |
| 61 | TESK2 | 0.90732359 |
| 62 | MAPK12 | 0.89374403 |
| 63 | TTN | 0.88828488 |
| 64 | MAP2K3 | 0.87163261 |
| 65 | RPS6KB2 | 0.86445017 |
| 66 | LATS2 | 0.85830703 |
| 67 | TBK1 | 0.81034285 |
| 68 | CHEK2 | 0.80377078 |
| 69 | LCK | 0.78639559 |
| 70 | STK24 | 0.78185430 |
| 71 | SIK1 | 0.76264832 |
| 72 | FGFR3 | 0.76047267 |
| 73 | TTK | 0.75797387 |
| 74 | PDK1 | 0.72770016 |
| 75 | PRKD2 | 0.72135486 |
| 76 | HIPK2 | 0.71986839 |
| 77 | TEC | 0.71412638 |
| 78 | LATS1 | 0.71268792 |
| 79 | CDK7 | 0.70843920 |
| 80 | TRPM7 | 0.70800609 |
| 81 | RPS6KC1 | 0.69787711 |
| 82 | RPS6KL1 | 0.69787711 |
| 83 | CDC7 | 0.69633944 |
| 84 | RPS6KA6 | 0.68472617 |
| 85 | LYN | 0.67776411 |
| 86 | PTK6 | 0.66683617 |
| 87 | IKBKB | 0.66354555 |
| 88 | EPHA3 | 0.66246899 |
| 89 | MAPK15 | 0.64753408 |
| 90 | KDR | 0.64601966 |
| 91 | MTOR | 0.63637310 |
| 92 | CHUK | 0.63526724 |
| 93 | TAOK3 | 0.60851654 |
| 94 | AURKB | 0.60271416 |
| 95 | CLK1 | 0.59532032 |
| 96 | MAP3K6 | 0.59478666 |
| 97 | CHEK1 | 0.58691137 |
| 98 | SIK2 | 0.58174255 |
| 99 | PRKCQ | 0.58020103 |
| 100 | FGFR2 | 0.57722955 |
| 101 | ALK | 0.57596390 |
| 102 | ICK | 0.57255095 |
| 103 | MAP3K1 | 0.57128479 |
| 104 | PDPK1 | 0.55214167 |
| 105 | EPHA2 | 0.54834492 |
| 106 | IRAK2 | 0.54644109 |
| 107 | PAK2 | 0.53620370 |
| 108 | TYRO3 | 0.53049763 |
| 109 | PTK2B | 0.52647302 |
| 110 | PDGFRA | 0.52241759 |
| 111 | CAMKK1 | 0.51110186 |
| 112 | PINK1 | 0.50500010 |
| 113 | PDGFRB | 0.50266781 |
| 114 | IKBKE | 0.49608038 |
| 115 | MAPKAPK2 | 0.48536905 |
| 116 | MAP3K14 | 0.46321468 |
| 117 | RPS6KA2 | 0.46150435 |
| 118 | BCKDK | 0.46145650 |
| 119 | STK38 | 0.45106940 |
| 120 | DYRK1B | 0.45060012 |
| 121 | JAK2 | 0.44996945 |
| 122 | BMPR2 | 0.44964809 |
| 123 | IRAK4 | 0.44732386 |
| 124 | BUB1 | 0.44333067 |
| 125 | MAPK3 | 0.43627932 |
| 126 | PIK3CG | 0.42505978 |
| 127 | PLK4 | 0.40315101 |
| 128 | TLK1 | 0.39564185 |
| 129 | STK11 | 0.38463616 |
| 130 | PLK1 | 0.38212025 |
| 131 | PRKD1 | 0.37980744 |
| 132 | ABL1 | 0.37830799 |
| 133 | CAMK4 | 0.37811383 |
| 134 | BMX | 0.37559696 |
| 135 | MAPK7 | 0.37429464 |
| 136 | * CDK2 | 0.37272461 |
| 137 | EPHB1 | 0.36629038 |
| 138 | MAP3K3 | 0.35149794 |
| 139 | INSR | 0.35063500 |
| 140 | ZAK | 0.34994429 |
| 141 | EGFR | 0.34344727 |
| 142 | FYN | 0.34143809 |
| 143 | PRKAA2 | 0.33715770 |
| 144 | MAPK4 | 0.33273088 |
| 145 | CAMKK2 | 0.33096772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.66679775 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.08714712 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.01057018 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.94093895 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.28104387 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.24074832 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.17371532 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.08703015 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.05944506 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 1.74192686 |
| 11 | Cell cycle_Homo sapiens_hsa04110 | 1.71457084 |
| 12 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.70521044 |
| 13 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.69910302 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.66397988 |
| 15 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.63534894 |
| 16 | Base excision repair_Homo sapiens_hsa03410 | 1.61468537 |
| 17 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.61164752 |
| 18 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.59053789 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.57474724 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.57435544 |
| 21 | RNA transport_Homo sapiens_hsa03013 | 1.56942182 |
| 22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.55405699 |
| 23 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.52935147 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.47105747 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.46063348 |
| 26 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.45761905 |
| 27 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.45482507 |
| 28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.36975000 |
| 29 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.33346292 |
| 30 | Spliceosome_Homo sapiens_hsa03040 | 1.33079362 |
| 31 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.30573987 |
| 32 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.30556026 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.29970950 |
| 34 | HTLV-I infection_Homo sapiens_hsa05166 | 1.29746500 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.26458383 |
| 36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.20822433 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.16734936 |
| 38 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.16365061 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.14845377 |
| 40 | DNA replication_Homo sapiens_hsa03030 | 1.14779804 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.13600027 |
| 42 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.13007742 |
| 43 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.10045147 |
| 44 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.09842075 |
| 45 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.09665474 |
| 46 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.06096131 |
| 47 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.05093413 |
| 48 | RNA degradation_Homo sapiens_hsa03018 | 1.04097971 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 1.01195468 |
| 50 | Mismatch repair_Homo sapiens_hsa03430 | 1.01024641 |
| 51 | Influenza A_Homo sapiens_hsa05164 | 1.00675155 |
| 52 | Bladder cancer_Homo sapiens_hsa05219 | 0.98860966 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.97355010 |
| 54 | * Non-homologous end-joining_Homo sapiens_hsa03450 | 0.95894908 |
| 55 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.92347452 |
| 56 | Basal transcription factors_Homo sapiens_hsa03022 | 0.91937832 |
| 57 | Tuberculosis_Homo sapiens_hsa05152 | 0.91348938 |
| 58 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.89556285 |
| 59 | Adherens junction_Homo sapiens_hsa04520 | 0.89210141 |
| 60 | Viral myocarditis_Homo sapiens_hsa05416 | 0.89200268 |
| 61 | Prostate cancer_Homo sapiens_hsa05215 | 0.88406779 |
| 62 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.88320652 |
| 63 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.87403157 |
| 64 | Colorectal cancer_Homo sapiens_hsa05210 | 0.86445102 |
| 65 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.85735796 |
| 66 | Platelet activation_Homo sapiens_hsa04611 | 0.84747924 |
| 67 | Homologous recombination_Homo sapiens_hsa03440 | 0.84025045 |
| 68 | Malaria_Homo sapiens_hsa05144 | 0.83949127 |
| 69 | Lysine degradation_Homo sapiens_hsa00310 | 0.83814597 |
| 70 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.83696725 |
| 71 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.82463747 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.82433949 |
| 73 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.81887367 |
| 74 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.81418370 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79607999 |
| 76 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.79009239 |
| 77 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.78537955 |
| 78 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.77111989 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76467803 |
| 80 | Sulfur relay system_Homo sapiens_hsa04122 | 0.75927519 |
| 81 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.74431495 |
| 82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73030023 |
| 83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.71319011 |
| 84 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.70616109 |
| 85 | Insulin resistance_Homo sapiens_hsa04931 | 0.70028882 |
| 86 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.69304069 |
| 87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69169684 |
| 88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.69127859 |
| 89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.68738039 |
| 90 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.67757198 |
| 91 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.67096830 |
| 92 | Legionellosis_Homo sapiens_hsa05134 | 0.66461684 |
| 93 | Other glycan degradation_Homo sapiens_hsa00511 | 0.66278976 |
| 94 | ABC transporters_Homo sapiens_hsa02010 | 0.66012419 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65595855 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.65352186 |
| 97 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.65297234 |
| 98 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64600858 |
| 99 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.62886742 |
| 100 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.62657637 |
| 101 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.62307612 |
| 102 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.61965399 |
| 103 | Thyroid cancer_Homo sapiens_hsa05216 | 0.61935525 |
| 104 | RNA polymerase_Homo sapiens_hsa03020 | 0.61875262 |
| 105 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61644868 |
| 106 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.60659918 |
| 107 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59725541 |
| 108 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.59183038 |
| 109 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.58700634 |
| 110 | Lysosome_Homo sapiens_hsa04142 | 0.58472840 |
| 111 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.58460603 |
| 112 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58314470 |
| 113 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58189117 |
| 114 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.57209602 |
| 115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57043761 |
| 116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56500632 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55700005 |
| 118 | Pathways in cancer_Homo sapiens_hsa05200 | 0.54920679 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54128233 |
| 120 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54104798 |
| 121 | Focal adhesion_Homo sapiens_hsa04510 | 0.53566923 |
| 122 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53047722 |
| 123 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49558768 |
| 124 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48739643 |
| 125 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.48386265 |
| 126 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.48323160 |
| 127 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.48160958 |
| 128 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47381889 |
| 129 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.47234620 |
| 130 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47218010 |
| 131 | Glioma_Homo sapiens_hsa05214 | 0.46873512 |
| 132 | Phagosome_Homo sapiens_hsa04145 | 0.42580787 |
| 133 | Pertussis_Homo sapiens_hsa05133 | 0.42100806 |
| 134 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.40203748 |
| 135 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.39859274 |
| 136 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38586015 |
| 137 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.37181710 |
| 138 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.35898453 |
| 139 | Endocytosis_Homo sapiens_hsa04144 | 0.32966381 |
| 140 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.30665214 |
| 141 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.27282911 |

